Resources

Categories
  1. Acute leukemia: Drug trials show 50% cure rate

    "We were thrilled to see such a dramatic change even after only a single dose of the new drug. Nearly all of the lab mice's leukemia signs disappeared overnight," said Professor Ben-Neriah.

    Drug Trials 50% Cure rate

    Read more »
  2. Deleting two molecules boosts immune response

    "Our findings could provide an opportunity to improve future engineering of CAR T cells against tumors...."

    Cancer, 2 molecules

    Read more »
  3. Genetic model could be the ideal new tool for testing Parkinson's disease therapies.

    "We believe we've found an approach that is most relevant to humans, in that our models of gene dysfunction mimic the etiology of Parkinson's disease rather than its pathology....

    News on Parkinsons

    Read more »
  4. New research findings about Huntington's disease

    This opens up new treatment strategies for diseases that involve impairment of the body's ability to break down...

    News from research

    Read more »
  5. New subtype of multiple sclerosis discovered

    The breakthrough provides a better understanding of the individualized nature of the disease says the research team. 

    MS new type

    Read more »
  6. PRESS RELEASE: مشروع اجتماعي يوفر إمكانية الوصول إلى الأدوية المعتمدة من وكالة الأدوية الأوروبية وإدارة الغذاء والدواء في منطقة الشرق الأوسط

    GCC Press Release

    Read more »
  7. A cup of strawberries a day keeps the doctor away?

    New research shows the benefit of eating fresh fruit on colon diseases like IBD.

    News

    Read more »
  8. PRESS RELEASE: Good News for Migraine Sufferers

    UK Press Release

    Read more »
  9. PRESS RELEASE: ALS İÇİN YENİ TEDAVİLER UMUT OLUYOR

    Turkish Press Release

    Read more »
  10. Our safe and respectful approach to helping patients

    Industry NewsA recent UK documentary highlights the need for a service that protects patients and works with their trusted healthcare providers.

    Read more »
  11. Lower prices negotiated on 16 medicines

    Lower prices negotiated and provided as part of our ongoing mission to make medicines more accessible. 
    new prices 

    Read more »
  12. 2018 - Good year for new FDA approvals of cancer treatments

    2018 has been a good year for new cancer treatments says the U.S. AACR. 
    AACR news 

    Read more »
  13. Kisqali (ribociclib) approved for additional indications in HR+/HER2- advanced breast cancer

    News updateKisqali is now the only CDK4/6 inhibitor for use with an aromatase inhibitor for the treatment of pre-, peri- or postmenopausal women in the US.

    Read more »
  14. In-depth review of the new EMA-approved preventative migraine injection

    The approval marks a significant advance in the field of neurology — and one that migraine patients will no doubt welcome.

    News update


    Read more »
  15. Erenumab (Aimovig) now approved for the European Union

    The new preventive medicine for migraine Aimovig (erenumab) has been approved by the EMA. Read more...
    Breaking News 

    Read more »
  16. 10 important facts to know about the new migraine injection

    You might have heard about a new medicine that’s just been approved to treat migraine. Here’s what you need to know.

    Glasses

    Read more »
  17. A new answer for treating migraines?

    7 need-to-knows about migraine as well as some updates on the latest treatment developments

    Blog post

    Read more »
  18. FDA grants accelerated approval to the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for metastatic colorectal cancer

    Industry News

    Read more »
  19. Array BioPharma Announces FDA Approval of Braftovi (encorafenib) in Combination with Mektovi (binimetinib) for Unresectable or Metastatic Melanoma with BRAF Mutations

    Industry News

    Read more »
  20. What is ‘cold chain’ delivery?

    Find out about what it means to order and receive temperature-controlled medicines.

    Map

    Read more »
  21. Image of the Year shows exceptional responses to cancer treatment

    Industry NewsThe dramatic before-and-after images show eight men's incredible response to cutting-edge treatment. 

    Read more »
  22. What’s after platinum-based chemo?

    Dandelion (conceptual)A closer look at the function and efficicacy of niraparib as a maintenace treatment.

    Read more »
  23. New immunotherapy shows reduction in tumor size for NSCLC patients

    Industry NewsIt’s believed that this immunotherapy and its dual approach to fighting cancer will be a notable complement to existing immuno-oncology treatments.

    Read more »
  24. Response to Keytruda (pembrolizumab) better in older patients, study suggests

    Industry NewsResearchers believe these differences are due to a reduced immunosuppressive tumor environment in older patients.

    Read more »
  25. Full marketing authorisation for blinatumomab

    Industry NewsThe latest approval renders the previous 'temporary approval' a full approval, without further results needed.

    Read more »
  26. T-cell therapy yields objective response rate of 52% in lymphoma (DLBCL) patients

    Industry NewsThe 52% (95% CI, 41-62) ORR included a complete response rate of 40% and a partial response rate of 12%.

    Read more »
  27. A wearable device for opioid withdrawal?

    Industry NewsThe FDA has approved a wearable device to treat withdrawal symptoms such as agitation, anxiety, depression, and opiate cravings.

    Read more »
  28. Keytruda-chemo combination shows beneficial response in treating metastatic NSCLC

    Industry NewsResearchers say the addition of Keytruda (pembrolizumab) in this study almost doubled the response rate of chemo for patients with NSCLC.

    Read more »
  29. New study suggests men and women may benefit differently from some immunotherapy medications

    News updateThe study showed that the relative survival gain almost doubled in men, compared to female patients, regardless of the type of cancer and drugs given.

    Read more »
  30. Looking inside and looking ahead: everyone.org quarter in review

    TSM TeamOur quarterly review was an opportunity to take stock and support an organisation fuelled by a mission aligned to ours: to make the lives of other human beings better.

    Read more »
US 0